For years, gut health marketing has centred on one number: colony-forming units (CFUs). The higher the probiotic label’s count, the logic went, the better the product. The science has been quietly challenging that frame — and the emerging field of postbiotics offers a more mechanistically direct path to what most people actually want from a gut supplement: a more stable, resilient gut lining.
Probiotics vs Postbiotics: What the Terms Actually Mean
The International Scientific Association of Probiotics and Prebiotics (ISAPP) defines probiotics as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.” They are, by definition, living organisms that must survive manufacturing, storage, stomach acid, and bile salts before reaching the lower gut in numbers sufficient to do anything.
Postbiotics were formally defined by ISAPP in 2021 as “preparations of inanimate microorganisms and/or their components that confer a health benefit on the host.” In plain terms: the bioactive substances produced by microbes — or the microbes in a stabilised, inactivated form — that exert effects without needing to survive or colonise the gut at all (Salminen et al., 2021 — Nature Reviews Gastroenterology & Hepatology).
The practical consequence: probiotics require survival and colonisation to work; postbiotics do not. For many applications — particularly supporting the gut barrier — postbiotics offer a more consistent and directly targeted delivery mechanism than live culture products.
Why the Gut Barrier Matters More Than the Colony Count
The intestinal epithelium is a single-cell-thick layer that controls what crosses from the gut lumen into systemic circulation. Tight junction proteins hold these cells together. When that integrity is compromised, larger molecular structures can cross — a dynamic that has been associated with inflammatory and metabolic disruption in the research literature, though the full causal picture in humans is still being characterised.
Short-chain fatty acids (SCFAs) — primarily butyrate, propionate, and acetate — produced when gut bacteria ferment dietary fibre are among the most-studied compounds for maintaining this barrier. Butyrate functions as the primary energy source for colonocytes (the cells lining the colon) and has been shown in cellular and animal models to upregulate tight junction proteins and reduce permeability markers (Peng et al., 2009 — The Journal of Nutrition).
A 2011 review in the World Journal of Gastroenterology summarised evidence for butyrate across intestinal and extraintestinal contexts, documenting its role in epithelial cell energy metabolism, barrier function, and anti-inflammatory signalling (Canani et al., 2011 — World Journal of Gastroenterology). The evidence base remains strongest in mechanistic and animal studies; robust human intervention data specifically on barrier function is still growing. That context matters — but it also explains why postbiotic butyrate-delivery ingredients like tributyrin have attracted formulation interest: they bypass the dependence on your specific microbiome composition to produce butyrate endogenously.
The Supporting Stack: L-Glutamine and Zinc Carnosine
A postbiotic-oriented gut formula typically pairs its SCFA-delivery mechanism with compounds that support the epithelium through complementary pathways.
L-Glutamine is the most abundant amino acid in the bloodstream and the primary fuel source for enterocytes — the cells of the small intestinal lining. In metabolically demanding states, demand for glutamine rises sharply. A review in the International Journal of Molecular Sciences outlines glutamine’s roles in intestinal cell proliferation, tight junction support, and mucosal immunity, noting that adequate supply is necessary for normal gut barrier function (Kim & Kim, 2017 — IJMS).
Zinc carnosine is a chelate of zinc and L-carnosine studied specifically for gut mucosal support. A study published in Gut found that zinc carnosine stabilised small bowel integrity and stimulated gut repair processes in rodent models, and noted tolerability in human subjects at the tested dose (Mahmood et al., 2007 — Gut).
Neither compound is a live probiotic. Neither needs to colonise anything. Both target the mucosal lining from mechanistically distinct angles.
How We Built Primal Gut Around This Framework
Rather than competing in the probiotic CFU race, Primal Gut was formulated around the postbiotic-first logic above: CoreBiome® (a tributyrin-based postbiotic delivering a butyrate precursor) at 300mg, paired with 300mg L-glutamine and 75mg zinc carnosine. The aim is to support the environment the gut lining lives in — not to introduce more competitors into the ecosystem your trillions of resident bacteria have already negotiated.
It is taken as a morning capsule with your first meal, aligning with the digestive window when epithelial cell turnover is active and when a food-accompanied dose of these compounds is best absorbed.
Who Might Prioritise a Postbiotic-First Approach
The evidence is still building, and a gut supplement is not a substitute for medical care when you have a diagnosed condition. That said, the following contexts are where the postbiotic rationale is strongest:
- After a course of antibiotics — which disrupts microbial diversity, altering the microbiome’s capacity to generate SCFAs endogenously
- Frequent travellers whose gut is regularly exposed to novel microbial environments and dietary disruption
- Anyone with a pattern of gut sensitivity that doesn’t meet diagnostic thresholds but meaningfully affects daily comfort
- People who have tried multiple probiotic products without meaningful benefit
These are context and lifestyle observations, not diagnostic criteria. If gut symptoms concern you, speak with a gastroenterologist before choosing any supplement strategy.
Sources & Further Reading
- Salminen S, Collado MC, Endo A, et al. (2021). The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature Reviews Gastroenterology & Hepatology. doi:10.1038/s41575-021-00440-6
- Canani RB, Costanzo MD, Leone L, et al. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology. doi:10.3748/wjg.v17.i12.1519
- Peng L, Li ZR, Green RS, Holzman IR, Lin J (2009). Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. The Journal of Nutrition. doi:10.3945/jn.109.104638
- Kim MH, Kim H (2017). The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. International Journal of Molecular Sciences. doi:10.3390/ijms18051051
- Mahmood A, FitzGerald AJ, Marchbank T, et al. (2007). Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. doi:10.1136/gut.2006.099929
This article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any new supplement protocol, particularly if you have a diagnosed gastrointestinal condition or take medication.
0 comments